Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

SARIDON 250 MG/150 MG/50 MG COMPRIMIDOS - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/SARIDON 250 MG/150 MG/50 MG COMPRIMIDOS

Approved

STANDARD

SARIDON 250 MG/150 MG/50 MG COMPRIMIDOS

Bayer Uab🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Jun 30, 2025
Approval ID: 1a7cdf399ba4c0b7
Company: Bayer Uab
Type: Standard

Approval Details

Approval Id: 1a7cdf399ba4c0b7
Drug Cima Aemps Name: SARIDON 250 MG/150 MG/50 MG COMPRIMIDOS
Register Number: LT1940863001
Holder Company Name: Bayer Uab
Marketing Company Name: Abacus Medicine A/S
Authorization Date: 2025-06-30
Dosage Form: COMPRIMIDO
Dose: 250mg paracetamol/150mg propifenazona/50mg cafeína
Route Of Administration: VÍA ORAL
Prescription Type: Sin Receta
Commercialized: No
Company Name: Bayer Uab

Active Ingredients

PARACETAMOL

250 mg

PROPIFENAZONA

150 mg

CAFEINA

50 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jun 30, 2025

Approval ID

1a7cdf399ba4c0b7

Type

Standard

Back to CIMA-AEMPS Approvals